Pharmacy Medical News about S(+)-ketamine; experimental pain; cardiac output

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Statins and cancer risk

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

S(+)-ketamine Effect on Experimental Pain and Cardiac Output: A Population Pharmacokinetic-Pharmacodynamic Modeling Study in Healthy Volunteers
Anesthesiology, 09/14/09

Sigtermans M et al. – Low–dose ketamine behaves as an analgesic in the treatment of acute and chronic pain...Sex differences observed were restricted to pharmacokinetic model parameters, with a 20% greater elimination clearance of S(+)–ketamine and S(+)–norketamine in women resulting in higher drug plasma concentrations in men. S(+)–ketamine produced profound drug high and analgesia with six times greater potency in the heat pain than the electrical pain test. After ketamine–infusion, analgesia rapidly dissipated; in the heat pain test but not the electrical pain test, analgesia was followed by a period of hyperalgesia. Over the dose range tested, ketamine produced a 40–50% increase in cardiac output. A significant consistent contribution of S(+)–norketamine to overall effect was detected for none of the outcome parameters. S(+)–ketamine displays clinically relevant sex differences in its pharmacokinetics. It is a potent analgesic at already low plasma concentrations, but it is associated with intense side effects.

<< Previous
Enzyme therapy for the treatment of type 1 Gaucher disease:...

Next >>
Mechanosensitive TRP channels in cardiovascular pathophysiology